The selection of ventilation devices in children with mild or moderate upper respiratory tract infections: a randomised controlled trial

Author:

liu xiang1,tan xiaona1,cao hongyan1,qiao li1,shi jing1,shi lei1

Affiliation:

1. Children’s hospital of hebei province

Abstract

Abstract Background: Practicing anesthesia in children with upper respiratory tract infections ( URTI ) increases the risk of perioperative respiratory adverse events ( PRAE ). Several observational trials have shown the supraglottic airway is a potentially alternative for airway management in children. The purpose of the study was to determine the selection of ventilation devices in children with mild or moderate URTI. Methods: 80 children patients were included with mild or moderate URTI, and received either a laryngeal mask airway ( LMA ) or an endotracheal tube ( ETT ). Patients were observed for the appearance of any complications such as cough, laryngospasm, bronchospasm, breath-holding, postoperative stridor or desaturation less than 90% at the following times: induction of anesthesia, tube placement, during surgery, during tube removal, and in the postanesthesia care unit ( PACU ). Results: 41 children had PRAE in this study. Children receiving an endotracheal tube were more likely to have a PRAE than those who received a LMA (29 [72.5%] vs 12 [31.5%]; risk ratio ( RR )0.417, 95% confidence interval ( CI ), 0.248–0.701, P<0.0001). There was a significantly lower incidence of minor PRAE in the LMA group compared with the ETT group during intraoperatively ( RR 0.364, 95% CI 0.192-0.688, P=0.0001 ). There were differences between groups with respect to the incidence of perioperative cough ( P = 0.043 ) and desaturation ( P = 0.031 ). Conclusions: The supraglottic airway reduced the incidence of coughing, bronchospasm, and oxygen desaturation, and provided an acceptable alternative to the ETT in children with mild or moderate URTI. Trial registration: This randomized controlled trial was approved by the ethics committee of children's hospital of hebei province (Number:165) and Chinese Clinical Trial Registry ( ChiCTR1900025530 ); The full date of first trial registration in the format(31/08/2019).

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3